The furor over gold in the past couple months has now leaked over into biotech land, with the FDA Trader newsletter from Agora Financial now catching your attention with the big bold word “GOLD” even as they pitch a “gold-based oncology protocol” that they say could set you up for 10,000% returns. Sounds a little […]
Articles
- Most Relevant
- Most Recent
Gold ProtocolTravis, Agora Financial/Technology Profits Confidential is hyping a ”Gold Protocol” approach to Cancer detection and treatment by a very small company that is supposed to make a PMA application to the FDA in the first Quarter of 2017. They want you to subscribe to a special flash drive presentation. This company is supposed to have […]
Ray Blanco is teasing about a certain company that uses Gold as a protocol to stop cancer. Can someone identify this company? jbinsc
Using nano gold to cure cancer.
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]
The timing actually works really well for the Friday File this week, because the teaser I want to sniff out for you is for a stock that happens to be insanely small and thinly traded — and I’d feel really bad about the inevitable exaggeration that would come from a mention of this company in […]
The Winklevoss twins came to talk to talk about Bitcoin. Which is definitely the least typical presentation I’ve seen at the Value Investing Congress — these are my notes from the talk. Bitcoin is a math-based asset created over a decentralized peer to peer network. They are hoping to convince us that Bitcoin will be […]
[ed note: Another piece from “Doc Gumshoe” today — Michael Jorrin is not a doctor, he’s a longtime medical writer who we love because he explains diseases, treatments, and health controversies in a way that makes sense. The words and opinions shared below are his alone. If you’re curious about whether rheumatoid arthritis matters to […]
Dear Folks, Can you sleuth out a new one promising 10,000 % returns. A small company about to roll out the most important part of its ” gold based oncology protocol. gold nanoparticles coated with proteins that seek out cancer cells and attack them. Pushed by Agora, FDA Trader, Ray Blanco. I saw this on […]
This one was sent in by a reader earlier today, so I thought I’d quickly get out a note about … this will be shorter than your average Gumshoe writeup, but hopefully still packed with pithy comments and one interesting stock idea. This is from Toby Smith for his $79 ChangeWave service, and it’s for […]
[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]
OK, OK, the questions on this one are getting a bit overwhelming — and I’m afraid that if I don’t cover this one soon the villagers will soon be gathering their fiery torches and marching on Castle Gumshoe … so here goes. Louis Basenese and the folks at Wall Street Daily are pitching his MicroCap […]
I’ve got a whole passel of things to comment on for you today — I want to update my thoughts on some insurance company stocks that I own and that I touted as beneficiaries of a big switch in the insurance market over the past year or so, check in on a buy and a […]
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
[Ed. Note: Here is the latest contribution from Dr. KSS, who writes for the Irregulars about medicine and biomedical stocks. As always, he has agreed to our trading restrictions and his words and thoughts are his own.] The Belle of the Everglades How To Profit From The Cure First of Two Parts Of the many […]
It’s been a wild ride for the past couple weeks of coronavirus panic, and this week has been especially crazy (and still isn’t quite over)… though it’s encouraging that my Real Money Portfolio has been a little bit stronger than the market so far this year — partly because of brilliant stock selection, I’d like […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. His topics, words and opinions are his own. Enjoy!] It’s the second reel of conspiracy film Shooter, and Mark Wahlberg, whom government schemers are trying to frame for assassination, has just been shot twice. In the back of a stolen FBI car, […]
[ed. note: Michael Jorrin, who we like to call “Doc Gumshoe”, is a longtime medical writer who shares his thoughts with us a couple times a month. He is not a doctor, and his articles are not typically focused on investment ideas] This post will neither spook you nor cheer you up. In adding Doc […]
[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
This isn’t really about a new teaser pitch, but I’ve had lots of readers ask what’s going on with the flurry of changes at Palm Beach Research and MarketWise recently… so if you’re interested in that bit of publisher crisis, stick with me for a few minutes and I’ll share my perspective, a little back […]
Jeff Brown is pitching something he calls a “global token exchange” recently, abbreviating it “G.T.E.”, and reader questions are piling up on the doormat here at Gumshoe Manor, so it’s time to take a look… The basic spiel, which takes the form of a long presentation/interview between Jeff Brown and a hired talking head that […]
Apparently, Teeka’s “The Super Halving” event refers to a complete stop in new supply of Bitcoin that according to Teeka will happen this year instead of the originally intended year 2140 (120 years from now!). He claims that there will be 6 small altcoins that will see a price increase that will be much higher […]
Dear Friends Let’s keep the group “Paul Mampilly’s 100x deal” going Thank you
I’ve gotten a bunch of questions about Teeka Tiwari’s “Trump Tower” teaser pitch recently, so although the ad is actually very old now (it’s still got a January 29, 2020 date under the signature) I thought I’d re-share our solution. It is still circulating heavily, and it’s an ad for Palm Beach’s “entry level” newsletter […]
No doubt you have been hearing more about Cryptocurrencies – Bitcoin and Ethereum at least. You may have noticed Bitcoin and Ethereums huge gains and recent correction. Bitcoin was at $5000, then during halving around $7k-$10k, and recently at $41k. And it had a 26% correction/consolidation, as it was going up to fast. Partly due […]
This will surely not be the last time Doc Gumshoe turns his attention to the pandemic that is now imposing misery on many parts of the world. I need to acknowledge that when what was then generally called the Wuhan virus first came to my attention, I expressed the view that, despite the dire […]
It’s been a wild ride for the past couple weeks of coronavirus panic, and this week has been especially crazy (and still isn’t quite over)… though it’s encouraging that my Real Money Portfolio has been a little bit stronger than the market so far this year — partly because of brilliant stock selection, I’d like […]
I guess now pretty much everyone has jumped aboard the Marijuana bandwagon — the Motley Fool is a bit later to the party, having just announced its Marijuana Masters investing service ($1,499, no refunds), helmed by David Kretzmann (a new name to me), so let’s see what it is that the typically much more mainstream […]
We will no longer be publishing the commentary of Dr. KSS, who wrote about biotech stocks for the Irregulars for several years. Late last week, he decided to move on and resign from his work here. I imagine he will likely start his own publication of some sort in the future — all I know […]
Pretty much every publisher has jumped on the cryptocurrency bandwagon, and this latest one shouldn’t come as much of a surprise… Jim Rickards has styled himself as a currency guru, with his “Currency Wars Alert” and plenty of pitches about the impending demise of the dollar or other major currency moves in recent years, and […]
[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). A company called Anthera (ANTH) is trialling blisibimod, an oral agent that does the same thing. […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
Ray Blanco is teasing about a certain company that uses Gold as a protocol to stop cancer. Can someone identify this company? jbinsc
Using nano gold to cure cancer.
The first version of this story was published on July 28, 2016 under the headline Palm Beach: “Issuing a strong ‘buy’ recommendation for ‘the next Bitcoin.’” Tom Dyson, Teeka Tiwari’s publisher at Palm Beach, has a new pitch out for these cryptocurrencies, which he calls “Bit Shares,” again touting Ethereum and Bitcoin but also adding […]
Travis, Agora Financial/Technology Profits Confidential is hyping a ”Gold Protocol” approach to Cancer detection and treatment by a very small company that is supposed to make a PMA application to the FDA in the first Quarter of 2017. They want you to subscribe to a special flash drive presentation. This company is supposed to have […]
Recent Comments
There's a recent article about this on this site. Search for "gold protocol"....